Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
ming gao
CONTACT
Lead
Sinocelltech Ltd.
A randomized, double-blind, parallel-controlled, multicenter phase 3 clinical trial. 560 patients with non-resectable locally advanced, metastatic or recurrent non-squamous cell non-small cell lung cancer (NSCLC) were randomly divided into two groups (SCT510 group and bevacizumab group) at a 1:1 ratio, and the treatment included combination chemotherapy and maintenance treatment, followed by follow-up.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted